| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | -2,977 | -2,741 |
| Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents | -22,176 | -22,444 |
| Cash and cash equivalents at beginning of period | 193,860 | - |
| Cash and cash equivalents at end of period | 171,684 | - |
agilon health, inc. (AGL)
agilon health, inc. (AGL)